Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Inpatient psychiatry

Effective treatments and fewer measures that restrict freedom

    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
  • 2 minute read

The results of the 2022 quality measures in adult and child and adolescent psychiatry have been published. They show that inpatient treatments led to a significant decrease in patients’ average symptom burden. The proportion of cases with at least one measure restricting freedom decreased compared with the previous year.

The annual quality measurements survey the symptom burden of patients as well as the frequency of measures restricting freedom in inpatient psychiatry. As part of the measurement of symptom burden, patients as well as treating hospital staff assessed how physical and psychological complaints and other symptoms developed between admission and discharge. In adult psychiatry, the average symptom burden decreased significantly during the hospital stay. From the patients’ perspective, it decreased at a similar rate as in the previous year; from the treatment providers’ perspective, the decrease was slightly greater than in 2021. Admission scores remained stable from both the patient and practitioner perspectives.

Symptom burden also reduced in children

In child and adolescent psychiatry, inpatient treatments also clearly reduced the average symptom burden. In the self-assessment of the children and adolescents and in the external assessment by the clinic staff, the symptom burden at clinic admission was at the previous year’s level. The difference between admission and discharge was assessed similarly by the treatment providers as in 2021; in the patients’ self-assessment, the difference was smaller.

Fewer measures restricting freedom

In adult psychiatry, the proportion of cases with at least one measure restricting freedom across all hospital types (excluding forensic psychiatry) was 8.8%. Compared with 2021, this represents an average decrease of 0.8 percentage points. In child and adolescent psychiatry, the trend of a declining number of cases continued. With a share of 5.8%, there was a sharp decrease of one percentage point compared with the previous year.

Protection of the persons concerned

When interpreting the results, it should be noted that measures restricting freedom are used to protect patients as well as their environment. Therefore, a low number does not automatically indicate better treatment quality.

Source: «Stationäre Psychiatrie: Wirksame Behandlungen und weniger Freiheitsbeschränkende Massnahmen im Jahr 2022», 17.10.2023, Nationaler Verein für Qualitätsentwicklung in Spitälern und Kliniken (ANQ).

InFo NEUROLOGIE & PSYCHIATRIE 2023; 21(5): 43
HAUSARZT PRAXIS 2023: 18(12): 36

Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
  • HAUSARZT PRAXIS
Related Topics
  • freedom restriction
  • inpatient psychiatry
  • measures restricting freedom
  • Psychiatry
Previous Article
  • IBD and exposure to altitude

Don’t fly so high, sick patient

  • Congress Reports
  • Gastroenterology and Hepatology
  • General Internal Medicine
  • RX
  • Studies
View Post
Next Article
  • SGLT-2-i in type 2 diabetes and CVD

Cardioprotective mechanisms of action of empagliflozin – what’s new?

  • Cardiology
  • Congress Reports
  • Endocrinology and Diabetology
  • General Internal Medicine
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 8 min
  • Benefits, limits and safety aspects

Phytotherapy for cardiovascular diseases

    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 6 min
  • Results of the FOREST HCM study

Symptomatic obstructive hypertrophic cardiomyopathy

    • Cardiology
    • Education
    • RX
    • Studies
View Post
  • 9 min
  • Neuroprotection, resilience and cognitive health in old age

Longevity & Brain

    • Education
    • General Internal Medicine
    • Geriatrics
    • Neurology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 6 min
  • Obesity as a chronic disease: an interdisciplinary perspective

Neurobiological mechanisms of obesity

    • Congress Reports
    • General Internal Medicine
    • Nutrition
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 5 min
  • Oncolytic virus in stage II melanoma

Innovative method for predicting therapy response

    • Dermatology and venereology
    • Education
    • Oncology
    • RX
    • Studies
View Post
  • 3 min
  • Phimosis and penile cancer under SGLT2i

Increased risk for men with T2D

    • Congress Reports
    • Endocrinology and Diabetology
    • General Internal Medicine
    • RX
    • Studies
    • Urology
View Post
  • 12 min
  • Diabetic ketoacidosis

Recommendations for action in practice

    • Cases
    • CME continuing education
    • Emergency and intensive care medicine
    • Endocrinology and Diabetology
    • Hematology
    • Nephrology
    • RX
View Post
  • 6 min
  • Migraine: better quality of life thanks to multimodal care

Broader selection of innovative migraine prophylactics and acute therapies

    • Congress Reports
    • Neurology
    • Pharmacology and toxicology
    • RX
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Causes and prevention at work
  • 2
    Yellow nail and Swyer-James syndrome
  • 3
    Recommendations for action in practice
  • 4
    From the β-cell to the center: the versatile role of amylin
  • 5
    Communication as the key to therapy adherence

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.